Skip to content

FINGER Robot Therapy Study

Study of Influence of Timing on Motor Learning

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02048826
Enrollment
31
Registered
2014-01-29
Start date
2013-11-30
Completion date
2016-02-29
Last updated
2021-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebrovascular Accident

Keywords

stroke

Brief summary

The purpose of this study is to determine the effectiveness of training hand movement using FINGER robot after stroke. FINGER is a robot that measures finger movements and allows users to play computer games using those movements.

Detailed description

Robotic devices can be used to retrain movement after stroke. However, it is unclear how best to assist in movement. Providing physical assistance may improve the flow of proprioceptive information to the nervous system, which may help a person relearn to move a limb. On the other hand, assisting movement with a robot may cause a person to slack, not trying as hard during therapy. This study will test the effect of different levels of assistance on recovery of finger function during robot-assisted therapy after stroke.

Interventions

DEVICEFINGER I

FINGER is a robot that measures finger movements and allows patients to play computer game using those movements. Patients will be exercising with FINGER using setting I

DEVICEFINGER II

FINGER is a robot that measures finger movements and allows patients to play computer game using those movements. Patients will be exercising with FINGER using setting II

Sponsors

University of California, Irvine
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Age 18 to 80 years of age * Have history of stroke affecting the arm, at least 6 months prior to enrollment * have arm and/or hand weakness as measured on a standard clinical scale * do not have active major psychological problems, or problems affecting the stroke-affected arm or hand besides the stroke * do not have active major brain disease other than the stroke * have absence of pain in the stroke-affected arm and hand

Exclusion criteria

* severe stiffness of the arm or hand as measured on a standard clinical scale * severe problems speaking or understanding speech as measured on a standard clinical scale * severe reduced level of consciousness * severe loss ability to sense movement of your limbs as measured on a standard clinical scale * currently pregnant * difficulty in understanding or complying with the instructions given by the researcher * inability to perform the experimental task that will be studied * increased pain with movement of the stroke-affected arm or hand

Design outcomes

Primary

MeasureTime frameDescription
Motor and Strength Outcome Measure Using Box and Block Test Measured in Units of Blocks PlacedFrom baseline to 1-month post therapyThe primary endpoint was the change in Box and Blocks score, which measures how many blocks a subject can pick up and place in a box in 60 seconds, from baseline to 1-month post-therapy. The higher the scores, the better arm and hand function indicated.

Secondary

MeasureTime frameDescription
Motor and Strength Measure Using Action Research Arm Test Measured as a ScoreFrom baseline to 1-month post therapyWe compared the change in Action Research Arm Test (ARAT) scores from the baseline evaluation to 1-month post-therapy evaluation. The ARAT is a 57-point scale, 0 being the minimum scoreand 57 being the maximum score, that measures upper extremity function, coordination, and dexterity. The higher scores indicate a better outcome.
Motor, Strength and Sensory Using Fugl-Meyer Test Measured as a ScoreFrom baseline to 1-month post therapyThe primary outcome measure was the change in Upper Extremity Fugl-Meyer score on a scale of 0 to 66 at one-month post-therapy. The higher the scores, the better arm and hand function indicated.

Countries

United States

Participant flow

Participants by arm

ArmCount
FINGER I
Subjects participate in 3 weeks of exercising with the experimental device: FINGER robot with first setting at a minimum of 3 days per week, 1 hour per day with the exercise program FINGER I: FINGER is a robot that measures finger movements and allows patients to play computer game using those movements. Patients will be exercising with FINGER using setting I FINGER II: FINGER is a robot that measures finger movements and allows patients to play computer game using those movements. Patients will be exercising with FINGER using setting II
15
FINGER II
Subjects participate in 3 weeks of exercising with the experimental device: FINGER robot with a second setting at a minimum of 3 days per week, 1 hour per day with the exercise program FINGER I: FINGER is a robot that measures finger movements and allows patients to play computer game using those movements. Patients will be exercising with FINGER using setting I FINGER II: FINGER is a robot that measures finger movements and allows patients to play computer game using those movements. Patients will be exercising with FINGER using setting II
15
Total30

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyWithdrawal by Subject10

Baseline characteristics

CharacteristicFINGER IFINGER IITotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
3 Participants9 Participants12 Participants
Age, Categorical
Between 18 and 65 years
12 Participants6 Participants18 Participants
Region of Enrollment
United States
15 participants15 participants30 participants
Sex: Female, Male
Female
6 Participants11 Participants17 Participants
Sex: Female, Male
Male
9 Participants4 Participants13 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 160 / 15
other
Total, other adverse events
0 / 160 / 15
serious
Total, serious adverse events
0 / 160 / 15

Outcome results

Primary

Motor and Strength Outcome Measure Using Box and Block Test Measured in Units of Blocks Placed

The primary endpoint was the change in Box and Blocks score, which measures how many blocks a subject can pick up and place in a box in 60 seconds, from baseline to 1-month post-therapy. The higher the scores, the better arm and hand function indicated.

Time frame: From baseline to 1-month post therapy

Population: The number of blocks participants able to pick up and place in a box in 60 seconds at one month follow up minus the number of blocks participants able to pick up and place in a box in 60 seconds at baseline.

ArmMeasureValue (MEAN)Dispersion
FINGER IMotor and Strength Outcome Measure Using Box and Block Test Measured in Units of Blocks Placed2.3 blocksStandard Deviation 3.7
FINGER IIMotor and Strength Outcome Measure Using Box and Block Test Measured in Units of Blocks Placed2.4 blocksStandard Deviation 4.6
Secondary

Motor and Strength Measure Using Action Research Arm Test Measured as a Score

We compared the change in Action Research Arm Test (ARAT) scores from the baseline evaluation to 1-month post-therapy evaluation. The ARAT is a 57-point scale, 0 being the minimum scoreand 57 being the maximum score, that measures upper extremity function, coordination, and dexterity. The higher scores indicate a better outcome.

Time frame: From baseline to 1-month post therapy

Population: The ARAT score at one-month post-therapy minus ARAT score at baseline on a 57 point scale.

ArmMeasureValue (MEAN)Dispersion
FINGER IMotor and Strength Measure Using Action Research Arm Test Measured as a Score2.5 scores on a scaleStandard Deviation 3.7
FINGER IIMotor and Strength Measure Using Action Research Arm Test Measured as a Score3.5 scores on a scaleStandard Deviation 4.9
Secondary

Motor, Strength and Sensory Using Fugl-Meyer Test Measured as a Score

The primary outcome measure was the change in Upper Extremity Fugl-Meyer score on a scale of 0 to 66 at one-month post-therapy. The higher the scores, the better arm and hand function indicated.

Time frame: From baseline to 1-month post therapy

Population: Fugl-Meyer score at one-month post-therapy minus Fugl-Meyer score at baseline on a 66 point scale.

ArmMeasureValue (MEAN)Dispersion
FINGER IMotor, Strength and Sensory Using Fugl-Meyer Test Measured as a Score3.7 units on a scaleStandard Deviation 3.3
FINGER IIMotor, Strength and Sensory Using Fugl-Meyer Test Measured as a Score1.8 units on a scaleStandard Deviation 1.9

Source: ClinicalTrials.gov · Data processed: Feb 22, 2026